Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

Clinical trial NCT04138719 · RECRUITING

Trial details

NCT number: NCT04138719
Sponsor: Hebei Medical University Fourth Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Triple-negative Breast Cancer Nab-paclitaxel

Start date: 2019-11-20
Primary completion: 2026-10-20
Enrollment: 520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.